82 FR 13050 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 82, Issue 44 (March 8, 2017)
Federal Motor Carrier Safety Administration
Federal Register Volume 82, Issue 44 (March 8, 2017)
| Page Range | 13050-13056 | |
| FR Document | 2017-04524 |
[Federal Register Volume 82, Number 44 (Wednesday, March 8, 2017)] [Notices] [Pages 13050-13056] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-04524] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2016-0383] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA). ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 41 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before April 7, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2016-0383 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any [[Page 13051]] personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 41 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Joseph A. Akers Mr. Akers, 24, has had ITDM since 2007. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Akers understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Akers meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from West Virginia. Leslie R. Auger Mr. Auger, 58, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Auger understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Auger meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Missouri. Ta Canunpa W. Banks Mr. Banks, 32, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Banks understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Banks meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from South Dakota. Ralph E. Beard Mr. Beard, 53, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Beard understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Beard meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class C CDL from Michigan. Darrell W. Britnell Mr. Britnell, 50, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Britnell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Britnell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from North Carolina. Paul M. Capeder Mr. Capeder, 56, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Capeder understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV [[Page 13052]] safely. Mr. Capeder meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Minnesota. Robert D. Carnazzo Mr. Carnazzo, 47, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carnazzo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carnazzo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Massachusetts. Randall C. Coleman Mr. Coleman, 64, has had ITDM since 1998. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Coleman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Coleman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative and stable proliferative diabetic retinopathy. He holds an operator's license from Washington. Thomas K. Coleman Mr. Coleman, 24, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Coleman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Coleman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from North Carolina. Mark A. Cologne Mr. Cologne, 52, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cologne understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cologne meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Louisiana. Christopher J. Comstock Mr. Comstock, 28, has had ITDM since 2000. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Comstock understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Comstock meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Texas. Alexander H. Cromartie Mr. Cromartie, 64, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cromartie understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cromartie meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Michael R. Dark Mr. Dark, 36, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Dark understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dark meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Texas. Joseph P. Dellavolpe Mr. Dellavolpe, 67, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Dellavolpe understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dellavolpe meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Shea E. Durand Mr. Durand, 28, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the [[Page 13053]] assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Durand understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Durand meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New York. David L. Farris Mr. Farris, 55, has had ITDM since 1990. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Farris understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Farris meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Kansas. Donald D. Fown Mr. Fown, 58, has had ITDM since 2003. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Fown understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Fown meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Ohio. Michael L. Gamache Mr. Gamache, 55, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Gamache understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gamache meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Hampshire. David P. Glaeser Mr. Glaeser, 48, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Glaeser understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Glaeser meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Colorado. Donald J. Gray Mr. Gray, 58, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Gray understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gray meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from California. James E. Guthrie, IV Mr. Guthrie, 22, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Guthrie understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Guthrie meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kentucky. James F. Hamilton Mr. Hamilton, 60, has had ITDM since 2009. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hamilton understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hamilton meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from South Dakota. Paul R. Hanson Mr. Hanson, 54, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hanson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hanson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. [[Page 13054]] Jaculyn E. Heck Ms. Heck, 51, has had ITDM since 1999. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Heck understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Heck meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she has stable nonproliferative diabetic retinopathy. She holds an operator's license from Delaware. Greg J. Isom Mr. Isom, 31, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Isom understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Isom meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Georgia. Mark J. Johnson Mr. Johnson, 63, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Johnson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Johnson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. Tyson C. Johnson Mr. Johnson, 34, has had ITDM since 1994. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Johnson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Johnson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class B CDL from Pennsylvania. Darrell W. Luck Mr. Luck, 67, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Luck understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Luck meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Carolina. Gregory L. Markin Mr. Markin, 48, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Markin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Markin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Patrick May Mr. May, 61, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. May understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. May meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Maryland. Elbert J. Means Mr. Means, 65, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Means understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Means meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Carolina. Peter R. Meyer Mr. Meyer, 54, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Meyer understands [[Page 13055]] diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Meyer meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. Andrew R. Morris Mr. Morris, 24, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Morris understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Morris meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. Timothy A. Parks, Jr. Mr. Parks, 24, has had ITDM since 2010. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Parks understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Parks meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Maryland. Dennis Pitt Mr. Pitt, 54, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Pitt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Pitt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Antonio R. Ragin Mr. Ragin, 43, has had ITDM since 1997. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Ragin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Ragin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Connecticut. Matthew Reynolds Mr. Reynolds, 54, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Reynolds understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Reynolds meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Robert G. Smith Mr. Smith, 57, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Massachusetts. Patricia M. Spurgeon Ms. Spurgeon, 63, has had ITDM since 2014. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Spurgeon understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Spurgeon meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class C CDL from New York. Robert M. Sypolt Mr. Sypolt, 54, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Sypolt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sypolt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from West Virginia. Brandon R. Wedding Mr. Wedding, 32, has had ITDM since 2016. His endocrinologist examined him [[Page 13056]] in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Wedding understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wedding meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Oregon. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C.. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0383 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0383 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: February 28, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017-04524 Filed 3-7-17; 8:45 am] BILLING CODE 4910-EX-P
![13050 Federal Register / Vol. 82, No. 44 / Wednesday, March 8, 2017 / Notices
As of February 18, 2017, and in Dennis R. O’Dell Jr. (OK) the exemptions of the aforementioned
accordance with 49 U.S.C. 31136(e) and Jerry W. Parker (OH) drivers from the vision requirement in
31315, the following 30 individuals Gary W. Phelps (PA) 49 CFR 391.41(b)(10), subject to the
have satisfied the conditions for Charles D. Reddick (GA) requirements cited above (49 CFR
obtaining a renewed exemption from the Myriam Rodriguez (CA) 391.64(b)). In accordance with 49 U.S.C.
vision requirements (80 FR 2473; 80 FR Bobby L. Rupe (TX) 31136(e) and 31315, each exemption
Jules M. Sancho, Jr. (LA)
18693): Frank Santak (DE) will be valid for two years unless
David C. Berger (PA) Gary Wanek (NE) revoked earlier by FMCSA.
Raymond L. Bradshaw (TX) Keith Washington (IL) Issued on: February 28, 2017.
Jeffrey L. Coachman (NY) Kenneth J. Weaver (WY) Larry W. Minor,
Robert W. Cushing (NH) Cameron R. Whitford (NY) Associate Administrator for Policy.
Kenneth Dionisi (MI) The drivers were included on the [FR Doc. 2017–04526 Filed 3–7–17; 8:45 am]
Wolfgang K. Faulkingham (ME) following docket: Docket No. FMCSA–
BILLING CODE 4910–EX–P
Ricky J. Franklin (OR) 2002–12432; FMCSA–2004–19477;
James P. Gapinski (MN) FMCSA–2006–26066; FMCSA–2008–
David N. Groff (PA) 0266; FMCSA–2009–0321; FMCSA– DEPARTMENT OF TRANSPORTATION
Robert J. Hansen (MN) 2010–0114; FMCSA–2010–0187;
Kevin L. Himes (CO) FMCSA–2010–0354; FMCSA–2010– Federal Motor Carrier Safety
Jackie Lee (FL) 0385; FMCSA–2012–0040; FMCSA– Administration
Keith A. Looney (AR) 2012–0337; FMCSA–2012–0338;
Van C. Mac (IL) FMCSA–2012–0339. Their exemptions [Docket No. FMCSA–2016–0383]
Chris D. McCance (IL) are effective as of February 25, 2017, Qualification of Drivers; Exemption
Michael W. McCann (VA) and will expire on February 25, 2019.
Preston Nehring (FL) Applications; Diabetes Mellitus
Dennis J. Oie (MN) Conditions and Requirements
AGENCY: Federal Motor Carrier Safety
Leonardo Polonski (MA) The exemptions are extended subject Administration (FMCSA).
Don C. Powell (NY) to the following conditions: (1) Each ACTION: Notice of applications for
Luis Ramos (FL) driver must undergo an annual physical exemptions; request for comments.
Kevin C. Rich (NC) examination (a) by an ophthalmologist
Gerardo Silva (IL) or optometrist who attests that the SUMMARY: FMCSA announces receipt of
James A. Spittal (OR) vision in the better eye continues to applications from 41 individuals for
Paul J. Stewart (CO) meet the requirements in 49 CFR exemption from the prohibition against
David A. Stinelli (PA) 391.41(b)(10), and (b) by a certified persons with insulin-treated diabetes
Ingrid V. Taylor (MI) Medical Examiner, as defined by 49 CFR mellitus (ITDM) operating commercial
Bobby M. Warren (KY) 390.5, who attests that the driver is motor vehicles (CMVs) in interstate
Steven E. Williams (GA) otherwise physically qualified under 49 commerce. If granted, the exemptions
Vantha Yeam (PA) CFR 391.41; (2) each driver must would enable these individuals with
The drivers were included on the provide a copy of the ophthalmologist’s ITDM to operate CMVs in interstate
following docket: Docket No. FMCSA– or optometrist’s report to the Medical commerce.
2014–0300. Their exemptions are Examiner at the time of the annual
DATES: Comments must be received on
effective as of February 18, 2017, and medical examination; and (3) each
or before April 7, 2017.
will expire on February 18, 2019. driver must provide a copy of the
annual medical certification to the ADDRESSES: You may submit comments
As of February 25, 2017, and in bearing the Federal Docket Management
accordance with 49 U.S.C. 31136(e) and employer for retention in the driver’s
qualification file and retains a copy of System (FDMS) Docket No. FMCSA–
31315, the following 19 individuals 2016–0383 using any of the following
have satisfied the conditions for the certification on his/her person while
driving for presentation to a duly methods:
obtaining a renewed exemption from the • Federal eRulemaking Portal: Go to
vision requirements (67 FR 54525; 68 authorized Federal, State, or local
enforcement official. The exemption http://www.regulations.gov. Follow the
FR 8794; 69 FR 64806; 70 FR 2705; 70 on-line instructions for submitting
FR 8659; 71 FR 63380; 72 FR 1050; 72 will be rescinded if: (1) The person fails
to comply with the terms and comments.
FR 1056; 72 FR 5489; 73 FR 51689; 73 • Mail: Docket Management Facility;
FR 63047; 73 FR 76439; 74 FR 981; 74 conditions of the exemption; (2) the
exemption has resulted in a lower level U.S. Department of Transportation, 1200
FR 6207; 75 FR 1835; 75 FR 9482; 75 FR New Jersey Avenue SE., West Building
34209; 75 FR 47883; 75 FR 47886; 75 FR of safety than was maintained before it
was granted; or (3) continuation of the Ground Floor, Room W12–140,
63255; 75 FR 72863; 75 FR 77942; 75 FR Washington, DC 20590–0001.
exemption would not be consistent with
79083; 75 FR 79084; 76 FR 2190; 76 FR
the goals and objectives of 49 U.S.C. • Hand Delivery: West Building
4414; 76 FR 5425; 76 FR 8809; 77 FR Ground Floor, Room W12–140, 1200
31136(e) and 31315.
23799; 77 FR 33558; 77 FR 70534; 77 FR New Jersey Avenue SE., Washington,
74731; 77 FR 75496; 78 FR 1919; 78 FR IV. Preemption DC, between 9 a.m. and 5 p.m., e.t.,
9772; 78 FR 12811; 78 FR 12813; 78 FR During the period the exemption is in Monday through Friday, except Federal
12817; 80 FR 3723):
mstockstill on DSK3G9T082PROD with NOTICES
effect, no State shall enforce any law or Holidays.
William Audinwood (NY) regulation that conflicts with this • Fax: 1–202–493–2251.
Kenneth L. Bowers, Jr. (MN) exemption with respect to a person Instructions: Each submission must
Lester W. Carter (CA) operating under the exemption. include the Agency name and the
Matthew T. Eggers (IA) docket numbers for this notice. Note
Dennis E. Fisher (NY) VI. Conclusion that all comments received will be
Andrew G. Fornsel (NY) Based upon its evaluation of the 81 posted without change to http://
Jerry Hall (KY) exemption applications, FMCSA renews www.regulations.gov, including any
VerDate Sep<11>2014 19:27 Mar 07, 2017 Jkt 241001 PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM 08MRN1](https://thefederalregister.org/doc/82_FR_13094/page/1.svg)
![13056 Federal Register / Vol. 82, No. 44 / Wednesday, March 8, 2017 / Notices
in 2016 and certified that he has had no than other drivers, with the exception of DEPARTMENT OF VETERANS
severe hypoglycemic reactions resulting limited operating, monitoring and AFFAIRS
in loss of consciousness, requiring the medical requirements that are deemed
[OMB Control No. 2900–0657]
assistance of another person, or medically necessary.
resulting in impaired cognitive function The FMCSA concluded that all of the Agency Information Collection
that occurred without warning in the operating, monitoring and medical Activity: Conflicting Interests
past 12 months and no recurrent (2 or requirements set out in the September 3, Certification for Proprietary Schools
more) severe hypoglycemic episodes in 2003 notice, except as modified, were in Comment Request
the last 5 years. His endocrinologist compliance with section 4129(d).
certifies that Mr. Wedding understands Therefore, all of the requirements set AGENCY: Veterans Benefits
diabetes management and monitoring, out in the September 3, 2003 notice, Administration, Department of Veterans
has stable control of his diabetes using except as modified by the notice in the Affairs.
insulin, and is able to drive a CMV Federal Register on November 8, 2005 ACTION: Notice.
safely. Mr. Wedding meets the (70 FR 67777), remain in effect.
requirements of the vision standard at SUMMARY: The Veterans Benefits
49 CFR 391.41(b)(10). His optometrist IV. Submitting Comments Administration (VBA), Department of
examined him in 2016 and certified that Veterans Affairs (VA), is announcing an
You may submit your comments and
he does not have diabetic retinopathy. opportunity for public comment on the
material online or by fax, mail, or hand
He holds a Class A CDL from Oregon. proposed collection of certain
delivery, but please use only one of
information by the agency. Under the
III. Request for Comments these means. FMCSA recommends that
Paperwork Reduction Act (PRA) of
In accordance with 49 U.S.C. 31136(e) you include your name and a mailing
1995, Federal agencies are required to
and 31315, FMCSA requests public address, an email address, or a phone
publish notice in the Federal Register
comment from all interested persons on number in the body of your document
concerning each proposed collection of
the exemption petitions described in so that FMCSA can contact you if there
information, including each proposed
this notice. We will consider all are questions regarding your
revision of a currently approved
comments received before the close of submission.
collection, and allow 60 days for public
business on the closing date indicated To submit your comment online, go to comment in response to the notice. This
in the date section of the notice. http://www.regulations.gov and in the notice solicits comments on information
FMCSA notes that section 4129 of the search box insert the docket number needed to determine a claimant’s
Safe, Accountable, Flexible and FMCSA–2016–0383 and click the search entitlement to educational assistance.
Efficient Transportation Equity Act: A button. When the new screen appears,
DATES: Written comments and
Legacy for Users requires the Secretary click on the blue ‘‘Comment Now!’’
recommendations on the proposed
to revise its diabetes exemption program button on the right hand side of the
collection of information should be
established on September 3, 2003 (68 FR page. On the new page, enter
received on or before April 7, 2017.
52441).1 The revision must provide for information required including the
specific section of this document to ADDRESSES: Submit written comments
individual assessment of drivers with
diabetes mellitus, and be consistent which each comment applies, and on the collection of information through
with the criteria described in section provide a reason for each suggestion or Federal Docket Management System
4018 of the Transportation Equity Act recommendation. If you submit your (FDMS) at www.Regulations.gov or to
for the 21st Century (49 U.S.C. 31305). comments by mail or hand delivery, Nancy J. Kessinger, Veterans Benefits
Section 4129 requires: (1) Elimination submit them in an unbound format, no Administration (20M33), Department of
of the requirement for 3 years of larger than 81⁄2 by 11 inches, suitable for Veterans Affairs, 810 Vermont Avenue
experience operating CMVs while being copying and electronic filing. If you NW., Washington, DC 20420 or email to
treated with insulin; and (2) submit comments by mail and would nancy.kessinger@va.gov. Please refer to
establishment of a specified minimum like to know that they reached the ‘‘OMB Control No. 2900–0657’’ in any
period of insulin use to demonstrate facility, please enclose a stamped, self- correspondence. During the comment
stable control of diabetes before being addressed postcard or envelope. period, comments may be viewed online
allowed to operate a CMV. through the FDMS.
We will consider all comments and
In response to section 4129, FMCSA material received during the comment FOR FURTHER INFORMATION CONTACT:
made immediate revisions to the period. FMCSA may issue a final Nancy J. Kessinger at (202) 632–8924 or
diabetes exemption program established determination at any time after the close FAX (202) 632–8925.
by the September 3, 2003 notice. of the comment period. SUPPLEMENTARY INFORMATION: Under the
FMCSA discontinued use of the 3-year PRA of 1995 (Pub. L. 104–13; 44 U.S.C.
driving experience and fulfilled the V. Viewing Comments and Documents 3501–21), Federal agencies must obtain
requirements of section 4129 while To view comments, as well as any approval from the Office of Management
continuing to ensure that operation of documents mentioned in this preamble, and Budget (OMB) for each collection of
CMVs by drivers with ITDM will go to http://www.regulations.gov and in information they conduct or sponsor.
achieve the requisite level of safety the search box insert the docket number This request for comment is being made
required of all exemptions granted FMCSA–2016–0383 and click ‘‘Search.’’ pursuant to Section 3506(c)(2)(A) of the
under 49 U.S.C.. 31136 (e). Next, click ‘‘Open Docket Folder’’ and PRA.
Section 4129(d) also directed FMCSA With respect to the following
mstockstill on DSK3G9T082PROD with NOTICES
you will find all documents and
to ensure that drivers of CMVs with collection of information, VBA invites
comments related to this notice.
ITDM are not held to a higher standard comments on: (1) Whether the proposed
Issued on: February 28, 2017. collection of information is necessary
1 Section 4129(a) refers to the 2003 notice as a Larry W. Minor, for the proper performance of VBA’s
‘‘final rule.’’ However, the 2003 notice did not issue Associate Administrator for Policy.
a ‘‘final rule’’ but did establish the procedures and
functions, including whether the
standards for issuing exemptions for drivers with [FR Doc. 2017–04524 Filed 3–7–17; 8:45 am] information will have practical utility;
ITDM. BILLING CODE 4910–EX–P (2) the accuracy of VBA’s estimate of the
VerDate Sep<11>2014 17:34 Mar 07, 2017 Jkt 241001 PO 00000 Frm 00132 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM 08MRN1](https://thefederalregister.org/doc/82_FR_13094/page/7.svg)
Document Created: 2017-03-08 05:06:45
Document Modified: 2017-03-08 05:06:45
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before April 7, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 82 FR 13050 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR